american healthcare reit inc - AHR
AHR
Close Chg Chg %
48.36 -0.03 -0.06%
Open Market
48.33
-0.03 (0.06%)
Volume: 510.49K
Last Updated:
Dec 24, 2025, 12:59 PM EDT
Company Overview: american healthcare reit inc - AHR
AHR Key Data
| Open $48.43 | Day Range 48.00 - 48.53 |
| 52 Week Range 26.40 - 51.02 | Market Cap $8.97B |
| Shares Outstanding 185.51M | Public Float 184.03M |
| Beta 0.92 | Rev. Per Employee N/A |
| P/E Ratio 343.75 | EPS $0.14 |
| Yield 206.61% | Dividend $0.25 |
| EX-DIVIDEND DATE Dec 31, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.09M |
AHR Performance
| 1 Week | 0.56% | ||
| 1 Month | -4.69% | ||
| 3 Months | 14.83% | ||
| 1 Year | 69.94% | ||
| 5 Years | N/A |
AHR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
12
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | Average Target Price | 55.50 | |
| Number of Ratings | 12 | Current Quarters Estimate | 0.155 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 0.512 | |
| Last Quarter’s Earnings | 0.33 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.29 | Next Fiscal Year Estimate | 0.707 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 4 | 5 | 5 |
| Mean Estimate | 0.16 | 0.14 | 0.51 | 0.71 |
| High Estimates | 0.17 | 0.15 | 0.53 | 0.79 |
| Low Estimate | 0.13 | 0.14 | 0.49 | 0.58 |
| Coefficient of Variance | 10.21 | 3.49 | 3.23 | 11.38 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 10 | 10 | 9 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 1 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for American Healthcare Reit Inc - AHR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for American Healthcare Reit Inc - AHR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 8, 2025 | Brian S. Peay Chief Financial Officer | 180,074 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Brian S. Peay Chief Financial Officer | 176,637 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.79 per share | 5,438,653.23 |
| Apr 8, 2025 | Brian S. Peay Chief Financial Officer | 6,768 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Danny Prosky CEO & President; Director | 327,968 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Danny Prosky CEO & President; Director | 15,924 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Stefan K. L. Oh Chief Investment Officer | 97,289 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Stefan K. L. Oh Chief Investment Officer | 95,671 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.79 per share | 2,945,710.09 |
| Apr 8, 2025 | Stefan K. L. Oh Chief Investment Officer | 3,185 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Gabriel M. Willhite Chief Operating Officer | 150,863 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Gabriel M. Willhite Chief Operating Officer | 147,426 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.79 per share | 4,539,246.54 |
| Apr 8, 2025 | Gabriel M. Willhite Chief Operating Officer | 6,768 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Mark E. Foster EVP, GC & Secretary | 63,408 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Mark E. Foster EVP, GC & Secretary | 61,891 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.79 per share | 1,905,623.89 |
| Apr 8, 2025 | Mark E. Foster EVP, GC & Secretary | 2,986 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |